Larvol Delta - 89bio-Initiates-Phase-3-ENLIGHTENFibrosis-Trial-of-Pegozafermin-in-NonCirrhotic-Metabolic-DysfunctionAssociated-Steatohepatitis-MASH-Patients-with-Fibrosis

pegozafermin (BIO89-100) - 89Bio

https://www.globenewswire.com/news-release/2024/03/12/2844476/0/en/89bio-Initiates-Phase-3-ENLIGHTEN-Fibrosis-Trial-of-Pegozafermin-in-Non-Cirrhotic-Metabolic-Dysfunction-Associated-Steatohepatitis-MASH-Patients-with-Fibrosis.html

Mar 12, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next